↑(en) Citrome L, Goldberg JF, Portland KB, « Placing transdermal selegiline for major depressive disorder into clinical context: number needed to treat, number needed to harm, and likelihood to be helped or harmed », J Affect Disord, vol. 151, no 2, , p. 409–17 (PMID23890583, DOI10.1016/j.jad.2013.06.027)